Well Lead(603309) 上海证券报·2025-04-25 00:11Group 1 - The company has three wholly-owned subsidiaries: Weili Medical Technology Development (Suzhou) Co., Ltd., WELL LEAD GLOBAL LIMITED, and Guangdong Jieshang Medical Devices Co., Ltd. [1][2][4] - Weili Medical Technology Development (Suzhou) Co., Ltd. was established in December 2004 with a registered capital of 150 million yuan, focusing on medical device research, production, and sales [1] - WELL LEAD GLOBAL LIMITED was established in February 2024 with a registered capital of 10,000 Hong Kong dollars, engaged in the trade and investment of medical and related products [2] - Guangdong Jieshang Medical Devices Co., Ltd. was established in June 2024 with a registered capital of 50 million yuan, involved in the production and sales of various medical devices [4] Group 2 - The company provides guarantees for its wholly-owned subsidiaries based on their operational funding needs, ensuring smooth business operations and promoting stable development [5][6] - The total approved external guarantee amount is not more than 850 million yuan, accounting for 45.09% of the company's latest audited net assets attributable to shareholders [6] - The company has no overdue guarantees and maintains a good credit status for its subsidiaries [6][7] Group 3 - The company plans to reappoint Huaxing Accounting Firm (Special General Partnership) as its auditor for the 2025 fiscal year [7][8] - Huaxing Accounting Firm has a history dating back to 1981 and has provided auditing services to 91 listed companies in 2024, with total audited revenue of 370.37 million yuan [8] - The audit fee for the 2024 annual report is set at 1.1 million yuan, with a potential 20% fluctuation for the 2025 audit fee [16][19] Group 4 - The company has approved the addition of a new business address in Guangzhou and plans to amend its articles of association accordingly [22][23] - The new address is located at No. 47, Guomao Avenue South, Hualong Town, Panyu District, Guangzhou [22]